Sign in
Taking peopleNo phase

Pneumonia After Cardiovascular Surgery With Artificial Intelligence

Key facts

Who runs it
Tomsk National Research Medical Center of the Russian Academy of Sciences
Where
Russia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
700 people, planned
Started
29 Jul 2026
Expected to end
30 Sept 2028
Type of study
Observational
Treatments tested
  • Not applicable- observational study
Record updated
11 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Age ≥ 18 years
  • Cardiac and/or vascular surgical intervention during the current hospitalization
  • Signed informed consent from the patient for the use of their anonymized data for scientific purposes

Who cannot take part

  • Use of systemic antibacterial drugs within 30 days prior to the surgical intervention
  • Prescription of systemic antibacterial drugs during the hospitalization period for any indication other than hospital-acquired pneumonia
  • HIV infection

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Hospital acquired pneumonia

This trial is currently available in Russia.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This multicenter, prospective, observational study aims to address two primary objectives.

Read full original descriptionShow less

The first objective is to demonstrate that hospital-acquired pneumonia (nosocomial pneumonia) following cardiac surgery can be predicted using artificial intelligence (AI), and to develop a personalized risk calculator for its development.

The second objective is to demonstrate that hospital-acquired pneumonia can serve as a risk factor for a 1-year composite cardiovascular and pulmonary outcome after cardiac surgery, and to develop a personalized risk calculator for this composite outcome.

The composite outcome will include the occurrence of any of the following events:

* Respiratory death * Hospitalization for respiratory diseases * Development of oxygen dependence * New-onset asthma, COPD, or interstitial lung disease * Initiation or intensification of bronchodilator or corticosteroid therapy * Cardiovascular death * Acute myocardial infarction * Unstable angina * Myocardial revascularization * Acute ischemic stroke * Transient ischemic attack * Acute heart failure * Hospitalization for decompensated heart failure * New-onset atrial fibrillation or ventricular tachycardia * Initiation or intensification of antiarrhythmic therapy Both objectives will be addressed using artificial intelligence technologies applied during the data analysis phase.

This is a non-interventional study. Patient evaluation and treatment are conducted in strict accordance with approved standards of medical care for the respective conditions. No experimental or unregistered (not approved for use in the Russian Federation) medical or diagnostic procedures will be performed during this study.

The group in the trial

  • Patients after cardiovascular surgery

    Patients of 18 years and older, after cardiac and/or vascular surgical intervention during the current hospitalization, who signed informed consent for the use of their anonymized data for scientific purposes

    Treatment: Not applicable- observational study

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Hospital-acquired Pneumonia After Cardiovascular Surgery (CS): the Prediction and Assessment of Long-term Cardiovascular and Pulmonary Outcomes With Artificial Intelligence (AI) - (PNEUMONIA-CS-AI)
Criteria questions
Built from NCT07745491, who can take part
Record updated
11 August 2026